Meeting on the Med 2021 | Building the advanced therapies workforce in the UK

Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult, London, UK, highlights the importance of building the advanced therapies workforce to support the development and manufacture of therapies as the field continues to grow. He describes some of the approaches being undertaken by the Cell and Gene Therapy Catapult in the UK to enhance training and provide opportunities within the development, manufacturing and adoption phases of advanced therapeutics, such as the Advanced Therapy Skills Training Network, Advanced Therapy Treatment Centers and a range of apprenticeship programs. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.